The investment objective of the Fund is to provide long-term capital growth from an actively managed portfolio comprising listed equity and equity-related securities of companies in the healthcare sector or companies whose main activity involves holding investments in such companies or financing such companies.
The fund is actively managed and does not aim to replicate the performance of any index. However, the MSCI World Healthcare Index is used as a reference benchmark.
As the price of Shares in the Fund may fall as well as rise, the fund shall not be a suitable investment for an investor who cannot sustain a loss on their investment.
Past performance of the Fund should not be relied upon as an indicator of future performance.
Investment Risk: The value of investments and any income derived from them may fluctuate, and investors may not recover the full amount originally invested.
For a full list of risks, please refer to the Prospectus.
Disclaimer: Past performance is not indicative of future results.
All investments carry risk, and you may lose some or all of your investment.
| Fund Ticker | CARE SW |
| Exchange Listings | SIX, Xetra |
| NAV | $11.7228 |
| AUM | $9,988,257 |
| Share Class Assets | $9,988,257 |
| Daily NAV Change | -0.36% |
| Share Class Launch Date | 2025-09-15 |
| Fund Launch Date | 2025-09-15 |
| Share Class Currency | USD |
| Base Currency | USD |
| Asset Class | Equity |
| SFDR Classification | Article 8 |
| Total Expense Ratio (TER) | 0.55% |
| UCITS Compliant | Yes |
| UCITS Eligible | Yes |
| ISIN | IE000R6TN604 |
| Distribution Frequency | N/A |
| Use of Income | Accumulating |
| Domicile | Ireland |
| Product Structure | Active |
| Investment Manager | Bellevue Asset Management AG |
| Administrator | Northern Trust |
| Fiscal Year End | 31-Mar |
| Bloomberg Ticker | CARE SW |
| Custodian | Northern Trust |
| Portfolio Manager | Bellevue Asset Management AG |
| Issuer | Waystone ETF ICAV |
No. of holdings: 72
Download Full Holdings Report| Name | Sector | Country | Weights |
|---|---|---|---|
| ELI LILLY & CO | Pharmaceuticals | UNITED STATES | 9.83% |
| JOHNSON & JOHNSON COM USD1 | Pharmaceuticals | UNITED STATES | 7.93% |
| ABBVIE INC COM | Biotechnology | UNITED STATES | 5.17% |
| UNITEDHEALTH GROUP INC COM | Managed Health Care | UNITED STATES | 5.06% |
| ROCHE HLDG. | Pharmaceuticals | SWITZERLAND | 4.77% |
| MERCK & CO INC | Pharmaceuticals | UNITED STATES | 4.31% |
| NOVARTIS AG CHF0.49 (REGD) | Pharmaceuticals | SWITZERLAND | 3.38% |
| AMGEN INC COM | Biotechnology | UNITED STATES | 3.20% |
| THERMO FISHER SCIENTIFIC INC COM | Life Sciences Tools & Services | UNITED STATES | 3.17% |
| ASTRAZENECA ORD USD0.25 | Pharmaceuticals | UNITED KINGDOM | 2.89% |
| United States: 72.01% | Switzerland: 8.99% |
| United Kingdom: 5.4% | France: 3.23% |
| Japan: 3.16% | Denmark: 2.64% |
| Belgium: 1.32% | Australia: 1.03% |
| Germany: 0.58% | Israel: 0.41% |
| Finland: 0.36% | Sweden: 0.34% |
| Netherlands: 0% | Ireland: 0% |
| Pharmaceuticals: 42.02% | Health Care Equipment & Supplies: 20.49% |
| Biotechnology: 16.46% | Health Care Providers & Services: 12.48% |
| Life Sciences Tools & Services: 6.96% | Health Care Technology: 1.06% |
Germany 
Switzerland 
Ireland 
Singapore | Exchange | Ticker | RIC | SEDOL | CCY | Listing Date |
|---|---|---|---|---|---|
| SIX | CARE SW | CAREU.S | BVLK3L7 | $ | 2025-09-18 |
| SIX | CARECHF SW | CARECHF.S | BVK2L87 | CHF | 2025-09-18 |
| Xetra | C4RE GY | C4RE.DE | BVK2L98 | EUR | 2025-09-19 |
The fund does not engage in securities lending.
The information provided on this website is for informational purposes only and does not constitute financial advice. All investments carry risks, including the potential loss of capital. Past performance does not guarantee future results. Investors should review all relevant documents before making an investment decision.
By using this website, you agree to the terms and conditions outlined in our privacy policy and terms of service. This site complies with all relevant data privacy regulations, ensuring the confidentiality and protection of investor information.
Connect with
Our ETF Experts
Have questions or need guidance? Our team is here to help you navigate your investment journey with personalized support.
Sign up for our newsletter to get updates straight to your inbox
